[1]. [1]Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–170. MEDLINE |
CrossRef
[2]. [2]Gilbertsen VA. Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer. Cancer. 1973;34(Suppl. 9):.
[3]. [3]Al Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C
→
T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–232. MEDLINE |
CrossRef
[4]. [4]Jass JR. Colorectal polyposes: from phenotype to diagnosis. Pathol Res Pract. 2008;204:431–447.
CrossRef
[5]. [5]Nghiem Y, Cabrera M, Cupples CG, Miller JH. The mutY gene: a mutator locus in Escherichia coli that generates G.C–T.A transversions. Proc Natl Acad Sci USA. 1988;85:2709–2713. MEDLINE |
CrossRef
[6]. [6]Yeh YC, Chang DY, Masin J, Lu AL. Two nicking enzyme systems specific for mismatch-containing DNA in nuclear extracts from human cells. J Biol Chem. 1991;266:6480–6484. MEDLINE
[7]. [7]Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature. 1991;349:431–434. MEDLINE |
CrossRef
[8]. [8]Michaels ML, Miller JH. The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine). J Bacteriol. 1992;174:6321–6325. MEDLINE
[9]. [9]Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys. 2000;377:1–8. MEDLINE |
CrossRef
[10]. [10]Slupska MM, Luther WM, Chiang JH, Yang H, Miller JH. Functional expression of hMYH, a human homolog of the Escherichia coli MutY protein. J Bacteriol. 1999;181:6210–6213. MEDLINE
[11]. [11]Guan Y, Manuel RC, Arvai AS, et al. MutY catalytic core, mutant and bound adenine structures define specificity for DNA repair enzyme superfamily. Nat Struct Biol. 1998;5:1058–1064. MEDLINE |
CrossRef
[12]. [12]Fromme JC, Banerjee A, Huang SJ, Verdine GL. Structural basis for removal of adenine mispaired with 8-oxoguanine by MutY adenine DNA glycosylase. Nature. 2004;427:652–656.
CrossRef
[13]. [13]Noll DM, Gogos A, Granek JA, Clarke ND. The C-terminal domain of the adenine-DNA glycosylase MutY confers specificity for 8-oxoguanine.adenine mispairs and may have evolved from MutT, an 8-oxo-dGTPase. Biochemistry. 1999;38:6374–6379.
[14]. [14]Chmiel NH, Livingston AL, David SS. Insight into the functional consequences of inherited variants of the hMYH adenine glycosylase associated with colorectal cancer: complementation assays with hMYH variants and pre-steady-state kinetics of the corresponding mutated E. coli enzymes. J Mol Biol. 2003;327:431–443. MEDLINE |
CrossRef
[15]. [15]Volk DE, House PG, Thiviyanathan V, et al. Structural similarities between MutT and the C-terminal domain of MutY. Biochemistry. 2000;39:7331–7336.
[16]. [16]Parker A, Gu Y, Mahoney W, Lee SH, Singh KK, Lu AL. Human homolog of the MutY repair protein (hMYH) physically interacts with proteins involved in long patch DNA base excision repair. J Biol Chem. 2001;276:5547–5555. MEDLINE |
CrossRef
[17]. [17]Gu Y, Parker A, Wilson TM, Bai H, Chang DY, Lu AL. Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J Biol Chem. 2002;277:11135–11142. MEDLINE |
CrossRef
[18]. [18]Xie Y, Yang H, Miller JH, et al. Cells deficient in oxidative DNA damage repair genes Myh and Ogg1 are sensitive to oxidants with increased G2/M arrest and multinucleation. Carcinogenesis. 2008;29:722–728.
CrossRef
[19]. [19]Nielsen M, Joerink-van de Beld MC, Jones N, et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis. Gastroenterology. 2009;136:471–476. Abstract | Full Text |
Full-Text PDF (712 KB)
|
CrossRef
[20]. [20]Kim DW, Kim IJ, Kang HC, et al. Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas. Int J Colorectal Dis. 2007;22:1173–1178.
CrossRef
[21]. [21]Kim H, Kim HJ, Chi SG, et al. Absence of MutY homologue mutation in patients with multiple sporadic adenomatous polyps in Korea. World J Gastroenterol. 2006;12:951–955. MEDLINE
[22]. [22]Yanaru-Fujisawa R, Matsumoto T, Ushijima Y, et al. Genomic and functional analyses of MUTYH in Japanese patients with adenomatous polyposis. Clin Genet. 2008;73:545–553.
CrossRef
[23]. [23]Miyaki M, Iijima T, Yamaguchi T, et al. Germline mutations of the MYH gene in Japanese patients with multiple colorectal adenomas. Mutat Res. 2005;578:430–433. MEDLINE |
CrossRef
[24]. [24]Peterlongo P, Mitra N, Sanchez de AA, et al. Increased frequency of disease-causing MYH mutations in colon cancer families. Carcinogenesis. 2006;27:2243–2249. MEDLINE |
CrossRef
[25]. [25]Nielsen M, Franken PF, Reinards TH, et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet. 2005;42:e54.
[26]. [26]Gismondi V, Meta M, Bonelli L, et al. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer. 2004;109:680–684. MEDLINE |
CrossRef
[27]. [27]Dolwani S, Williams GT, West KP, et al. Analysis of inherited MYH/(MutYH) mutations in British Asian patients with colorectal cancer. Gut. 2007;56:593. MEDLINE |
CrossRef
[28]. [28]Gomez-Fernandez N, Castellvi-Bel S, Fernandez-Rozadilla C, et al. Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations?. BMC Med Genet. 2009;10:57.
CrossRef
[29]. [29]Kim JC, Ka IH, Lee YM, et al. MYH, OGG1, MTH1, and APC alterations involved in the colorectal tumorigenesis of Korean patients with multiple adenomas. Virchows Arch. 2007;450:311–319. MEDLINE |
CrossRef
[30]. [30]Livingston AL, Kundu S, Henderson PM, Anderson DW, David SS. Insight into the roles of tyrosine 82 and glycine 253 in the Escherichia coli adenine glycosylase MutY. Biochemistry. 2005;44:14179–14190.
[31]. [31]Wooden SH, Bassett HM, Wood TG, McCullough AK. Identification of critical residues required for the mutation avoidance function of human MutY (hMYH) and implications in colorectal cancer. Cancer Lett. 2004;205:89–95. Abstract | Full Text |
Full-Text PDF (154 KB)
|
CrossRef
[32]. [32]Pope MA, Chmiel NH, David SS. Insight into the functional consequences of hMYH variants associated with colorectal cancer: distinct differences in the adenine glycosylase activity and the response to AP endonucleases of Y150C and G365D murine MYH. DNA Repair (Amst). 2005;4:315–325. MEDLINE |
CrossRef
[33]. [33]Ali M, Kim H, Cleary S, Cupples C, Gallinger S, Bristow R. Characterization of mutant MUTYH proteins associated with familial colorectal cancer. Gastroenterology. 2008;135:499–507. Abstract | Full Text |
Full-Text PDF (1149 KB)
|
CrossRef
[34]. [34]Parker AR, Sieber OM, Shi C, et al. Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair. Carcinogenesis. 2005;26:2010–2018. MEDLINE |
CrossRef
[35]. [35]Francis AW, David SS. Escherichia coli MutY and Fpg utilize a processive mechanism for target location. Biochemistry. 2003;42:801–810.
[36]. [36]Tominaga Y, Ushijima Y, Tsuchimoto D, et al. MUTYH prevents OGG1 or APEX1 from inappropriately processing its substrate or reaction product with its C-terminal domain. Nucleic Acids Res. 2004;32:3198–3211.
CrossRef
[37]. [37]Kundu S, Brinkmeyer MK, Livingston AL, David SS. Adenine removal activity and bacterial complementation with the human MutY homologue (MUTYH) and Y165C, G382D, P391L and Q324R variants associated with colorectal cancer. DNA Repair (Amst). 2009;8:1400–1410.
CrossRef
[38]. [38]Molatore S, Russo MT, D’Agostino VG, et al. MUTYH mutations associated with familial adenomatous polyposis: functional characterization by a mammalian cell-based assay. Hum Mutat. 2010;31(2):159–166.
CrossRef
[39]. [39]Bai H, Jones S, Guan X, et al. Functional characterization of two human MutY homolog (hMYH) missense mutations (R227W and V232F) that lie within the putative hMSH6 binding domain and are associated with hMYH polyposis. Nucleic Acids Res. 2005;33:597–604.
CrossRef
[40]. [40]Bai H, Grist S, Gardner J, Suthers G, Wilson TM, Lu AL. Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposis. Cancer Lett. 2007;250:74–81. Abstract | Full Text |
Full-Text PDF (230 KB)
|
CrossRef
[41]. [41]Alhopuro P, Parker AR, Lehtonen R, et al. A novel functionally deficient MYH variant in individuals with colorectal adenomatous polyposis. Hum Mutat. 2005;26:393.
CrossRef
[42]. [42]Tao H, Shinmura K, Hanaoka T, et al. A novel splice-site variant of the base excision repair gene MYH is associated with production of an aberrant mRNA transcript encoding a truncated MYH protein not localized in the nucleus. Carcinogenesis. 2004;25:1859–1866. MEDLINE |
CrossRef
[43]. [43]Shinmura K, Yamaguchi S, Saitoh T, et al. Adenine excisional repair function of MYH protein on the adenine:8-hydroxyguanine base pair in double-stranded DNA. Nucleic Acids Res. 2000;28:4912–4918.
CrossRef
[44]. [44]Guillen-Ponce C, Castillejo A, Barbera VM, et al. Biallelic MYH germline mutations as cause of Muir-Torre syndrome. Fam Cancer. 2010;9(2):151–154.
CrossRef
[45]. [45]Croitoru ME, Cleary SP, Berk T, et al. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients. J Surg Oncol. 2007;95:499–506. MEDLINE |
CrossRef
[46]. [46]Sulova M, Zidkova K, Kleibl Z, et al. Mutation analysis of the MYH gene in unrelated Czech APC mutation-negative polyposis patients. Eur J Cancer. 2007;43:1617–1621. Abstract | Full Text |
Full-Text PDF (145 KB)
|
CrossRef
[47]. [47]Enholm S, Hienonen T, Suomalainen A, et al. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol. 2003;163:827–832. MEDLINE
[48]. [48]Croitoru ME, Cleary SP, Di Nicola N, et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst. 2004;96:1631–1634.
CrossRef
[49]. [49]Wang L, Baudhuin LM, Boardman LA, et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology. 2004;127:9–16. Abstract | Full Text |
Full-Text PDF (186 KB)
|
CrossRef
[50]. [50]Russell AM, Zhang J, Luz J, et al. Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients. Int J Cancer. 2006;118:1937–1940. MEDLINE |
CrossRef
[51]. [51]Ponti G, Venesio T, Losi L, et al. BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees. J Invest Dermatol. 2007;127:1387–1391.
CrossRef
[52]. [52]Lejeune S, Guillemot F, Triboulet JP, et al. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Hum Mutat. 2006;27:1064.
CrossRef
[53]. [53]Venesio T, Molatore S, Cattaneo F, Arrigoni A, Risio M, Ranzani GN. High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology. 2004;126:1681–1685. Abstract | Full Text |
Full-Text PDF (116 KB)
|
CrossRef
[54]. [54]Lefevre JH, Rodrigue CM, Mourra N, et al. Implication of MYH in colorectal polyposis. Ann Surg. 2006;244:874–879. MEDLINE |
CrossRef
[55]. [55]Nielsen M, Hes FJ, Nagengast FM, et al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis (AFAP). Clin Genet. 2007;71:427–433. MEDLINE |
CrossRef
[56]. [56]Aretz S, Uhlhaas S, Goergens H, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006;119:807–814. MEDLINE |
CrossRef
[57]. [57]Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 2003;362:39–41. Abstract | Full Text |
Full-Text PDF (68 KB)
|
CrossRef
[58]. [58]Balaguer F, Castellvi-Bel S, Castells A, et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case–control, population-based study. Clin Gastroenterol Hepatol. 2007;5:379–387. Abstract | Full Text |
Full-Text PDF (389 KB)
|
CrossRef
[59]. [59]Farrington SM, Tenesa A, Barnetson R, et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet. 2005;77:112–119. MEDLINE |
CrossRef
[60]. [60]Grunhage F, Jungck M, Lamberti C, et al. Contribution of common monoallelic MUTYH gene variants in German patients with familial colorectal cancer. Cancer Biomark. 2008;4:55–61.
[61]. [61]Avezzu A, Agostini M, Pucciarelli S, et al. The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle. Cancer Lett. 2008;268:308–313. Abstract | Full Text |
Full-Text PDF (223 KB)
|
CrossRef
[62]. [62]Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med. 2003;348:791–799.
CrossRef
[63]. [63]Fleischmann C, Peto J, Cheadle J, Shah B, Sampson J, Houlston RS. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer. 2004;109:554–558. MEDLINE |
CrossRef
[64]. [64]Halford SE, Rowan AJ, Lipton L, et al. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol. 2003;162:1545–1548. MEDLINE
[65]. [65]Kambara T, Whitehall VL, Spring KJ, et al. Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer. 2004;40:1–9. MEDLINE |
CrossRef
[66]. [66]Van Puijenbroek M, Nielsen M, Tops CM, et al. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G>T prescreening followed by MUTYH Hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin Cancer Res. 2008;14:139–142.
CrossRef
[67]. [67]Cleary SP, Cotterchio M, Jenkins MA, et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case–control study. Gastroenterology. 2009;136:1251–1260. Abstract | Full Text |
Full-Text PDF (339 KB)
|
CrossRef
[68]. [68]de Ferro SM, Suspiro A, Fidalgo P, et al. Aggressive phenotype of MYH-associated polyposis with jejunal cancer and intra-abdominal desmoid tumor: report of a case. Dis Colon Rectum. 2009;52:742–745.
[69]. [69]Jo WS, Bandipalliam P, Shannon KM, et al. Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol. 2005;3:1022–1028. Abstract | Full Text |
Full-Text PDF (184 KB)
|
CrossRef
[70]. [70]De Rosa M, Dourisboure RJ, Morelli G, et al. First genotype characterization of Argentinean FAP patients: identification of 14 novel APC mutations. Hum Mutat. 2004;23:523–524.
CrossRef
[71]. [71]Peterlongo P, Mitra N, Chuai S, et al. Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. Int J Cancer. 2005;114:505–507. MEDLINE |
CrossRef
[72]. [72]Riegert-Johnson DL, Johnson RA, Rabe KG, et al. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing. Genet Test. 2007;11:361–365.
CrossRef
[73]. [73]Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology. 2006;131:30–39. Abstract | Full Text |
Full-Text PDF (308 KB)
|
CrossRef
[74]. [74]Isidro G, Laranjeira F, Pires A, et al. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat. 2004;24:353–354.
CrossRef
[75]. [75]Colebatch A, Hitchins M, Williams R, Meagher A, Hawkins NJ, Ward RL. The role of MYH and microsatellite instability in the development of sporadic colorectal cancer. Br J Cancer. 2006;95:1239–1243. MEDLINE |
CrossRef
[76]. [76]Zhou XL, Djureinovic T, Werelius B, Lindmark G, Sun XF, Lindblom A. Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. Genet Test. 2005;9:147–151. MEDLINE |
CrossRef
[77]. [77]Stormorken A, Heintz K, Andresen PA, Møller P. MUTYH mutations do not cause HNPCC or late onset familial colorectal cancer. Hered Cancer Clin Pract. 2006;4:90–93.
[78]. [78]Lubbe SJ, Di Bernardo MC, Chandler IP, Houlston RS. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol. 2009;27:3975–3980.
CrossRef
[79]. [79]Vasen HF, Moslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008;57:704–713.
CrossRef
[80]. [80]Boparai KS, Dekker E, Eeden van S, et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis (Map). Gastroenterology. 2008;135(6):2014–2018. Abstract | Full Text |
Full-Text PDF (1955 KB)
|
CrossRef
[81]. [81]O'Shea AM, Cleary SP, Croitoru MA, et al. Pathological features of colorectal carcinomas in MYH-associated polyposis. Histopathology. 2008;53(2):184–194.
CrossRef
[82]. [82]Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology. 1996;110:682–687. Abstract |
Full-Text PDF (99 KB)
|
CrossRef
[83]. [83]Stigliano V, Assisi D, Cosimelli M, et al. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients. J Exp Clin Cancer Res. 2008;27:39.
[84]. [84]Dierssen JW, de Miranda NF, Ferrone S, et al. HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression. BMC Cancer. 2007;7:33. MEDLINE |
CrossRef
[85]. [85]Kloor M, Becker C, Benner A, et al. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res. 2005;65:6418–6424. MEDLINE |
CrossRef
[86]. [86]de Miranda NF, Nielsen M, Pereira D, et al. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression-a common event amongst DNA-repair-deficient colorectal cancers. J Pathol. 2009;219(1):69–76.
CrossRef
[87]. [87]Jones N, Vogt S, Nielsen M, et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology. 2009;137:489–494. Abstract | Full Text |
Full-Text PDF (279 KB)
|
CrossRef
[88]. [88]Casper M, Plotz G, Juengling B, Trojan J, Lammert F, Raedle J. Adenoma development in a patient with MUTYH-associated polyposis (MAP): new insights into the natural course of polyp development. Dig Dis Sci. 2010;55(6):1711–1715.
CrossRef
[89]. [89]Nielsen M, Hes FJ, Vasen HF, Van Den Hout WB. Cost-utility analysis of genetic screening in families of patients with germline MUTYH mutations. BMC Med Genet. 2007;8:42.
CrossRef
[90]. [90]Sakamoto K, Tominaga Y, Yamauchi K, et al. MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis. Cancer Res. 2007;67:6599–6604.
CrossRef
[91]. [91]Sieber OM, Howarth KM, Thirlwell C, et al. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Cancer Res. 2004;64:8876–8881. MEDLINE |
CrossRef
[92]. [92]Xie Y, Yang H, Cunanan C, et al. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res. 2004;64:3096–3102. MEDLINE |
CrossRef
[93]. [93]Vogt S, Jones N, Christian D, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137:1976–1985. Abstract | Full Text |
Full-Text PDF (598 KB)
|
CrossRef
[94]. [94]Buecher B, Baert-Desurmont S, Leborgne J, Humeau B, Olschwang S, Frebourg T. Duodenal adenocarcinoma and Mut Y human homologue-associated polyposis. Eur J Gastroenterol Hepatol. 2008;20:1024–1027.
CrossRef
[95]. [95]Zhang Y, Liu X, Fan Y, et al. Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China. Int J Cancer. 2006;119:2592–2596. MEDLINE |
CrossRef
[96]. [96]Goto M, Shinmura K, Yamada H, Tsuneyoshi T, Sugimura H. OGG1, MYH and MTH1 gene variants identified in gastric cancer patients exhibiting both 8-hydroxy-2′-deoxyguanosine accumulation and low inflammatory cell infiltration in their gastric mucosa. J Genet. 2008;87:181–186.
CrossRef
[97]. [97]Tricarico R, Bet P, Ciambotti B, et al. Endometrial cancer and somatic G
>
T KRAS transversion in patients with constitutional MUTYH biallelic mutations. Cancer Lett. 2009;274:266–270. Abstract | Full Text |
Full-Text PDF (160 KB)
|
CrossRef
[98]. [98]Barnetson RA, Devlin L, Miller J, et al. Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer. Clin Genet. 2007;72:551–555.
CrossRef
[99]. [99]Ashton KA, Proietto A, Otton G, Symonds I, Scott RJ. Genetic variants in MUTYH are not associated with endometrial cancer risk. Hered Cancer Clin Pract. 2009;7:3.
[100]. [100]Le Page F, Randrianarison V, Marot D, et al. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res. 2000;60:5548–5552. MEDLINE
[101]. [101]Zhang Y, Newcomb PA, Egan KM, et al. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:353–358. MEDLINE |
CrossRef
[102]. [102]Beiner ME, Zhang WW, Zhang S, Gallinger S, Sun P, Narod SA. Mutations of the MYH gene do not substantially contribute to the risk of breast cancer. Breast Cancer Res Treat. 2009;114:575–578.
CrossRef
[103]. [103]Ponti G, Ponz DL, Maffei S, et al. Attenuated familial adenomatous polyposis and Muir–Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet. 2005;68:442–447. MEDLINE |
CrossRef
[104]. [104]Baudhuin LM, Roberts LR, Enders FT, et al. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients. J Cancer Res Clin Oncol. 2006;132:159–162. MEDLINE |
CrossRef
[105]. [105]Akyerli CB, Ozbek U, Aydin-Sayitoglu M, Sirma S, Ozcelik T. Analysis of MYH Tyr165Cys and Gly382Asp variants in childhood leukemias. J Cancer Res Clin Oncol. 2003;129:604–605. MEDLINE |
CrossRef
[106]. [106]Shin EJ, Chappell E, Pethe V, et al. MYH mutations are rare in prostate cancer. J Cancer Res Clin Oncol. 2007;133:373–378. MEDLINE |
CrossRef
[107]. [107]Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control. 2009;21:289–300.
CrossRef
[108]. [108]Gorgens H, Muller A, Kruger S, et al. Analysis of the base excision repair genes MTH1, OGG1 and MUTYH in patients with squamous oral carcinomas. Oral Oncol. 2007;43:791–795. Abstract | Full Text |
Full-Text PDF (118 KB)
|
CrossRef
[109]. [109]Smith LM, Sharif S, Brand R, Fink E, Lamb J, Whitcomb DC. MUTYH exon 7 and 13 mutations associated with colorectal cancer (MAP syndrome) are not commonly associated with sporadic pancreatic cancer. Pancreatology. 2010;9:793–796.
CrossRef
[110]. [110]Al Tassan N, Eisen T, Maynard J, et al. Inherited variants in MYH are unlikely to contribute to the risk of lung carcinoma. Hum Genet. 2004;114:207–210. MEDLINE |
CrossRef
[111]. [111]Miyaishi A, Osawa K, Osawa Y, et al. MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J Exp Clin Cancer Res. 2009;28:10.
[112]. [112]jith Kumar VK, Gold JA, Mallon E, Thomas S, Hodgson SV. Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin. Fam Cancer. 2008;7:187–189.
CrossRef
[113]. [113]Baglioni S, Melean G, Gensini F, et al. A kindred with MYH-associated polyposis and pilomatricomas. Am J Med Genet A. 2005;134:212–214. MEDLINE
[114]. [114]Lipton L, Halford SE, Johnson V, et al. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res. 2003;63:7595–7599. MEDLINE
[115]. [115]Nielsen M, de Miranda NF, van PM, et al. Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas. BMC Cancer. 2009;9:184.
CrossRef
[116]. [116]Andreyev HJ, Norman AR, Cunningham D, et al. Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study. Br J Cancer. 2001;85:692–696. MEDLINE |
CrossRef
[117]. [117]Middeldorp A, van PM, Nielsen M, et al. High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas. J Pathol. 2008;216:25–31.
CrossRef
[118]. [118]Cardoso J, Molenaar L, de Menezes RX, et al. Chromosomal instability in MYH- and APC-mutant adenomatous polyps. Cancer Res. 2006;66:2514–2519. MEDLINE |
CrossRef
[119]. [119]Jones AM, Thirlwell C, Howarth KM, et al. Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas. J Pathol. 2007;213:249–256.
CrossRef
[120]. [120]Di Gregorio C, Frattini M, Maffei S, et al. Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis. Gastroenterology. 2006;131:439–444. Abstract | Full Text |
Full-Text PDF (429 KB)
|
CrossRef
[121]. [121]van der Post RS, Kets CM, Ligtenberg MJ, van Krieken JH, Hoogerbrugge N. Immunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis. Virchows Arch. 2009;454:25–29.
CrossRef
[122]. [122]Johnson V, Lipton LR, Cummings C, et al. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families. J Med Genet. 2005;42:756–762.
[123]. [123]Jones S, Emmerson P, Maynard J, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C--
>
T:A mutations. Hum Mol Genet. 2002;11:2961–2967. MEDLINE |
CrossRef
[124]. [124]Bougatef K, Marrakchi R, Kourda N, et al. Somatic mutation of MutYH in Tunisian patients with sporadic colorectal cancer. J Clin Lab Anal. 2007;21:372–374.
CrossRef
[125]. [125]Kim CJ, Cho YG, Park CH, et al. Genetic alterations of the MYH gene in gastric cancer. Oncogene. 2004;23:6820–6822. MEDLINE |
CrossRef
[126]. [126]Gushima M, Hirahashi M, Matsumoto T, et al. Altered expression of MUTYH and an increase in 8-hydroxydeoxyguanosine are early events in ulcerative colitis-associated carcinogenesis. J Pathol. 2009;219:77–86.
CrossRef
[127]. [127]Webb EL, Rudd MF, Houlston RS. Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet. 2006;79:768–771. MEDLINE |
CrossRef
[128]. [128]Kury S, Buecher B, Robiou-du-Pont S, et al. The thorough screening of the MUTYH gene in a large French cohort of sporadic colorectal cancers. Genet Test. 2007;11:373–379.
CrossRef
[129]. [129]Schafmayer C, Buch S, Egberts JH, et al. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer. 2007;121:555–558. MEDLINE |
CrossRef
[130]. [130]Tenesa A, Campbell H, Barnetson R, Porteous M, Dunlop M, Farrington SM. Association of MUTYH and colorectal cancer. Br J Cancer. 2006;95:239–242. MEDLINE |
CrossRef
[131]. [131]Kasahara M, Osawa K, Yoshida K, et al. Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. J Exp Clin Cancer Res. 2008;27:49.
[132]. [132]Picelli S, Zajac P, Zhou XL, et al. Common variants in human CRC genes as low-risk alleles. Eur J Cancer. 2010;46(6):1041–1048. Abstract | Full Text |
Full-Text PDF (136 KB)
|
CrossRef
[133]. [133]Tao H, Shinmura K, Suzuki M, et al. Association between genetic polymorphisms of the base excision repair gene MUTYH and increased colorectal cancer risk in a Japanese population. Cancer Sci. 2008;99:355–360.
CrossRef
[134]. [134]Jenkins MA, Croitoru ME, Monga N, et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev. 2006;15:312–314. MEDLINE |
CrossRef
[135]. [135]Tenesa A, Farrington SM, Dunlop MG: Re: . Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst. 2005;97:320–321.
CrossRef
[136]. [136]Ashton KA, Meldrum CJ, McPhillips L, Kairupan CF, Scott J. Frequency of the common MYH mutations (G382D and Y165C) in MMR mutation positive and negative HNPCC patients. Hered Cancer Clin Pract. 2005;3:65–70.
[137]. [137]Gorgens H, Kruger S, Kuhlisch E, et al. Microsatellite stable colorectal cancers in clinically suspected hereditary nonpolyposis colorectal cancer patients without vertical transmission of disease are unlikely to be caused by biallelic germline mutations in MYH. J Mol Diagn. 2006;8:178–182. MEDLINE |
CrossRef
[138]. [138]Eliason K, Hendrickson BC, Judkins T, et al. The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients. J Med Genet. 2005;42:95–96.
[139]. [139]Kim IJ, Ku JL, Kang HC, et al. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients. Hum Genet. 2004;115:498–503. MEDLINE |
CrossRef
[140]. [140]Mazurek A, Berardini M, Fishel R. Activation of human MutS homologs by 8-oxo-guanine DNA damage. J Biol Chem. 2002;277:8260–8266. MEDLINE |
CrossRef
[141]. [141]Macpherson P, Barone F, Maga G, Mazzei F, Karran P, Bignami M. 8-oxoguanine incorporation into DNA repeats in vitro and mismatch recognition by MutSalpha. Nucleic Acids Res. 2005;33:5094–5105.
CrossRef
[142]. [142]Zhao J, Winkler ME. Reduction of GC
→
TA transversion mutation by overexpression of MutS in Escherichia coli K-12. J Bacteriol. 2000;182:5025–5028. MEDLINE |
CrossRef
[143]. [143]Niessen RC, Sijmons RH, Ou J, et al. MUTYH and the mismatch repair system: partners in crime?. Hum Genet. 2006;119:206–211. MEDLINE |
CrossRef
[144]. [144]Giraldez MD, Balaguer F, Caldes T, et al. Association of MUTYH and MSH6 germline mutations in colorectal cancer patients. Fam Cancer. 2009;8:525–531.
CrossRef
[145]. [145]Steinke V, Rahner N, Morak M, et al. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients. Eur J Hum Genet. 2008;16:587–592.
CrossRef
[146]. [146]Van Puijenbroek M, Nielsen M, Reinards TH, et al. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family. Fam Cancer. 2007;6(1):43–51.
CrossRef
[147]. [147]Kairupan CF, Meldrum CJ, Crooks R, et al. Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations. Int J Cancer. 2005;116:73–77. MEDLINE |
CrossRef
[148]. [148]Matsumoto Y, Zhang QM, Takao M, Yasui A, Yonei S. Escherichia coli Nth and human hNTH1 DNA glycosylases are involved in removal of 8-oxoguanine from 8-oxoguanine/guanine mispairs in DNA. Nucleic Acids Res. 2001;29:1975–1981.
CrossRef
[149]. [149]Hazra TK, Das A, Das S, Choudhury S, Kow YW, Roy R. Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair (Amst). 2007;6:470–480. MEDLINE
[150]. [150]Dallosso AR, Dolwani S, Jones N, et al. Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3. Gut. 2008;57:1252–1255.
CrossRef
[151]. [151]Broderick P, Bagratuni T, Vijayakrishnan J, Lubbe S, Chandler I, Houlston RS. Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial colorectal cancer predisposition. BMC Cancer. 2006;6:243. MEDLINE |
CrossRef
[152]. [152]Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog. 2005;42:127–141. MEDLINE |
CrossRef